US20210401439A1 - Intrasaccular device positioning and deployment system - Google Patents

Images

Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
  • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
  • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
  • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
  • A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
  • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
  • A61B17/12027—Type of occlusion
  • A61B17/12031—Type of occlusion complete occlusion
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
  • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
  • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
  • A61B17/12136—Balloons
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
  • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
  • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
  • A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
  • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
  • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
  • A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
  • A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B2017/00743—Type of operation; Specification of treatment sites
  • A61B2017/00778—Operations on blood vessels
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B2017/00831—Material properties
  • A61B2017/00867—Material properties shape memory effect
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
  • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
  • A61B2017/1205—Introduction devices
  • A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
  • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
  • A61B2017/1205—Introduction devices
  • A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
  • A61B2017/12081—Details concerning the detachment of the occluding device from the introduction device detachable by inflation

Definitions

• the present invention generally relates to medical instruments, and more particularly, delivery systems for a device for aneurysm therapy.
• Cranial aneurysms can be complicated and difficult to treat due to their proximity to critical brain tissues.
• Prior solutions have included endovascular treatment whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow.
• Current alternatives to endovascular or other surgical approaches can include occlusion devices that either fill the sac of the aneurysm with embolic material or treating the entrance or neck of the aneurysm. Both approaches attempt to prevent blood flow into the aneurysm. When filling an aneurysm sac, the embolic material clots the blood, creating a thrombotic mass within the aneurysm.
• Naturally formed thrombotic masses formed by treating the entrance of the aneurysm with embolic coils can improve healing compared to aneurysm masses packed with embolic coils by reducing possible distention from arterial walls and permitting reintegration into the original parent vessel shape along the neck plane.
• embolic coils delivered to the neck of the aneurysm can potentially have the adverse effect of impeding the flow of blood in the adjoining blood vessel; at the same time, if the entrance is insufficiently packed, blood flow can persist into the aneurysm.
• Properly implanting embolic coils is therefore challenging, and once implanted, the coils cannot easily be retracted or repositioned.
• embolic coils do not always effectively treat aneurysms as aneurysms treated with multiple coils often reanalyze or compact because of poor coiling, lack of coverage across the aneurysm neck, because of flow, or even aneurysm size.
• the devices generally can include a braided implant that can be detachably attached to a delivery tube by an expansion ring that can be positioned within a notch on an outer surface of the delivery tube near a distal end of the delivery tube.
• the implant can be positioned within a lumen of the delivery tube and remain attached to the delivery tube as the delivery tube and implant device assembly is fed through a microcatheter to a treatment site.
• the braided implant can be implanted by pushing an inner elongated member, or pusher distally, thereby pushing the braided implant out of the distal end of the delivery tube.
• the inner elongated member can be detachably attached to an end of the braided implant such that the braided implant can be retracted and repositioned until properly positioned, then released.
• the expansion ring can move from a collapsed configuration that is engaged with the notch of the delivery tube to a deployed configuration that releases the delivery tube. Once released, the delivery tube can be extracted from the patient, leaving behind the implanted braided implant.
• An example system for releasing an implant can include a braided implant, a delivery tube, an inner elongated member, and an expansion ring.
• the braided implant can have a first end detachably attached to a distal end of the inner elongated member and a second end mechanically connected to the expansion ring.
• the delivery tube can have a distal end with a notch positioned on an outer surface near the distal end of the delivery tube.
• the expansion ring can be movable from a collapsed configuration that is engaged with the notch to a deployed configuration that is disengaged from the notch and released from the delivery tube.
• the braided implant can include a fold positioned distal the distal end of the delivery tube, an outer fold segment extending proximally from the fold, and an inner fold segment extending proximally from the fold such that the outer fold segment encompasses the inner fold segment.
• the outer fold segment can include the second end of the braided implant attached to the expansion ring, and the inner fold segment can include the first end attached to the inner elongated member.
• the delivery tube can have a lumen therethrough and the inner fold segment of the braided implant can be positioned within the lumen.
• the expansion ring can be mechanically connected to a portion of the outer fold segment such that the outer fold segment covers at least a portion of the notch and at least a portion of the expansion ring.
• the expansion ring can include an attached segment and an extending portion.
• the attached segment can be attached to the braided implant and can open a first region of the occlusive sack to a first circumference
• the extending portion can be attached to the attaching segment and can open a second region of the occlusive sack to a second circumference greater than the first circumference.
• the expansion ring can have leaf shaped elements that extend radially as the expansion ring moves from the collapsed configuration to the deployed configuration.
• the expansion ring can have segments joined to form a substantially tubular zig-zag structure when in the collapsed configuration.
• the inner elongated member can be pushed distally to implant at least a portion of the braided implant.
• An example device for treating an aneurysm can include a tubular delivery member, an inner elongated member, a braided tubular implant, and an expansion component.
• the braided tubular implant can be movable from a delivery configuration to an implanted configuration.
• the braided tubular implant can have a first end extending proximally within an interior of the tubular delivery member that is detachably attached to a distal end of the inner elongated member and a second end extending distally from the distal end of the tubular delivery member and folding proximally over at least a portion of a notch positioned on an exterior of the tubular delivery member near a distal end of the tubular delivery member.
• the expansion component can be positioned within the notch on the tubular delivery member and attached to the braided tubular implant near the second end of the braided tubular implant.
• the expansion component can be movable from a collapsed configuration engaging the notch to a deployed configuration disengaging the notch.
• the notch on the exterior of the tubular delivery member can be a circumferential indentation.
• the expansion component can be positioned in the circumferential indentation when in the collapsed configuration.
• the braided tubular implant When in the implanted configuration, the braided tubular implant can have an occlusive sack and the expansion component can be positioned within the occlusive sack.
• the expansion component can have extending members that appose the occlusive sack when the expansion component is in the deployed configuration.
• the expansion component When in the collapsed configuration, the expansion component can have an opening through which the braided tubular implant passes through upon movement from the delivery configuration to the implanted configuration.
• An example method for treating an aneurysm can include the steps of providing a braided implantation delivery system having a braided implant, a delivery tube, and an expansion component, attaching the braided implant to the expansion component, engaging the expansion component with a notch on the delivery tube, implanting the braided implant in the aneurysm, expanding the expansion component to disengage the expansion component from the notch, and releasing the expansion component from the delivery tube which releases the braided implant from the delivery tube.
• the method can further include the step of expanding the expansion component to occlude at least a portion of the neck of the aneurysm.
• the step of implanting the braided implant in the aneurysm can include the step of forming an occlusive sack, and the step of expanding the expansion component can include the step of extending the occlusive sack across the neck of the aneurysm.
• the provided braided implantation delivery system can further include an inner elongated member, and the method can further include the step of attaching the braided implant to the inner elongated member.
• the step of implanting the braided implant can further include the steps of pushing the inner elongated member distally, thereby pushing a portion of the braided implant into the aneurysm and detaching the braided implant from the inner elongated member.
• FIG. 1 is a cross-sectional drawing of an implantation device or system according to the present invention
• FIG. 2A is a drawing depicting braided implant in a delivery configuration according to the present invention.
• FIG. 2B is a drawing depicting an expansion ring in a collapsed configuration according to the present invention.
• FIG. 2C is a drawing depicting a distal end of a delivery tube according to the present invention.
• FIG. 3 is a drawing depicting a distal end of an implantation system according to the present invention.
• FIG. 4 is a cross-sectional drawing of an implantation system within a microcatheter according to the present invention.
• FIGS. 5A to 5G are drawings illustrating a method of use of an implantation system according to the present invention.
• FIG. 6 is a drawing depicting a braided implant in an implanted configuration with an expansion ring in a deployed configuration according to the present invention
• FIG. 7A is a cut-away drawing of an aneurysm with a partially implanted braided implant.
• FIG. 7B is a cut-away drawing of an aneurysm with a completely implanted braided implant.
• FIGS. 8A to 8C is drawing depicting a braided implant in an implanted configuration and an expansion ring in a deployed configuration according to the present invention
• FIGS. 9A to 9B is a drawing depicting a braided implant in an implanted configuration and an expansion ring in a deployed configuration according to the present invention
• FIGS. 10A, and 10B are drawings depicting expansion rings in a collapsed configuration according to the present invention.
• FIGS. 11 and 12 are flow diagrams outlining method steps according to the present invention.
• Treating the aneurysm with the braided implant can have potential advantages over treatments utilizing embolic coils such as an ability to achieve higher packing density, ability to retract and reposition the implant during the implantation procedure, ability to perform implantation without ancillary devices such as stents or balloons, reduced risk of reanalyzing or compacting, and improved coverage across the aneurysm neck, for example.
• the delivery system can also serve to at least partially occlude the neck of the aneurysm.
• the present disclosure describes various example systems, devices, and methods that can be utilized for at least such purposes.
• the system for positioning and deployment of an intrasaccular device e.g. braided implant
• an intrasaccular device e.g. braided implant
• the outer pusher delivery tube
• a first (proximal) end of the braided implant can be mounted to a distal end of the outer pusher, while a second (distal) end of the braided implant can be attached to a distal end of the inner pusher.
• the first end of the braided implant can have a self-expanding ring mounted to the braid.
• the self-expanding ring can be made of Nitinol or other similar self-expanding material.
• the self-expanding ring can be crimped in place within a notch located at a distal end of the outer pusher to attach the braided implant to the outer pusher, and the first, proximal end of the braided implant can fit within a notch at the distal end of the inner pusher.
• the inner pusher can include a release mechanism of known design. For example, see U.S. Pat. Nos. 7,377,932 and 8,062,325, each incorporated herein, in their entirety, by reference.
• FIG. 1 depicts a cross-sectional view of an implantation device 100 having a braided implant 300 , a delivery tube 500 , and an inner elongated member 400 .
• the braided implant 300 can have an outer fold segment 302 near a distal end 314 of the braided implant 300 .
• the outer fold segment 302 can be attached to an expansion ring 200 , and the expansion ring 200 can be positioned within a notch 510 on an outer surface 508 of the delivery tube 500 near a distal end 514 of the delivery tube 500 .
• the braided implant can have a fold 303 positioned distal the distal end 514 of the delivery tube 500 such that the outer fold segment 302 extends proximally from the fold 303 over the delivery tube 500 and an inner fold segment 304 extends proximally from the fold 303 within the delivery tube 500 .
• the inner fold segment 304 can extend to a proximal end 312 of the braided implant 300 , and a distal end 414 of the inner elongated member 400 can be detachably attached to the proximal end 312 of the braided implant 300 .
• the delivery tube 500 and the inner elongated member 400 can each have proximal ends 512 , 412 that can be accessible by a user for manipulation of the device 100 during treatment.
• FIGS. 2A to 2C depict a braided implant 300 , an expansion ring 200 , and a delivery tube 500 that can be assembled to form at least part of an implantation device, such as the device 100 depicted in FIG. 1 .
• FIG. 2A depicts the braided implant 300 in a delivery configuration having an outer fold segment 302 separated from an inner fold segment 304 by a fold 303 .
• the inner fold 304 can be sized to fit within a lumen 504 of the delivery tube 504 such as the delivery tube 500 depicted in FIG. 2C .
• the inner fold 304 can extend to a first end 312 that can attach to an inner elongated member (not shown).
• the outer fold segment 302 can be positioned at a second end 314 of the braided implant and can be sized to fit over an expansion ring 200 , such as the expansion ring 200 depicted in FIG. 2B .
• the outer fold segment 302 can also be sized to fit over a distal end 514 of a delivery tube 500 such as the delivery tube depicted in FIG. 2C .
• FIG. 2B depicts the expansion ring 200 in a collapsed configuration.
• the expansion ring 200 can be sized to fit within a notch 510 on an outer surface 508 of a delivery tube 500 such as the delivery tube 500 depicted in FIG. 2C .
• the expansion ring 200 can include extending portions 210 that are attached by attaching segments 220 to form a ring having an opening 240 sized to fit within the delivery tube notch 510 .
• Each extending portion 210 can have a petal or oval shape such as shown in FIG. 2B , and the shape can be characterized by a first width 216 at a base of the extending portion 210 and a second width 218 near a middle of the extending portion that is wider than the first width 216 .
• FIG. 2C depicts a portion of a delivery tube 500 near a distal end 514 of the delivery tube 500 .
• the delivery tube 500 can have notch 510 near its distal end 514 on its outer surface 508 , and the delivery tube 500 can have a lumen 504 therethrough.
• FIG. 3 depicts a braided implant 300 , expansion ring 200 , and delivery tube 500 such as those depicted in FIGS. 2A to 2C assembled together to form an implantation device.
• an outer fold segment 302 of the braided implant 300 can be folded over and attached to an expansion ring 200 , and the expansion ring 200 can be sized to fit within a notch 510 on an outer surface 508 of the delivery tube 500 .
• An inner fold segment 304 of the braided implant 300 can extend into a lumen 504 of the delivery tube. Configured thusly, the depicted device can be inserted into a microcatheter for delivery to a treatment site.
• FIG. 4 depicts a cross-sectional view of an implantation system including a device 100 positioned within a microcatheter 600 for delivery to a treatment site.
• the microcatheter can be any catheter suitable for insertion into a patient and navigation to a treatment site. Once in place, the implantation device 100 can be fed through the catheter 600 to the treatment site.
• the catheter 600 can have a distal end 614 that can be positioned at a treatment site and a proximal end 612 that can be accessible to a user during a treatment procedure.
• FIGS. 5A to 5G are cross-sectional drawings illustrating a method of use of an implantation system for treatment of an aneurysm.
• FIG. 5A depicts an implantation system configured to begin implantation of the braided implant. As shown, the device can be approximately aligned with a distal end 614 of the microcatheter 600 .
• the braided implant 300 can be attached to an expansion ring 200 within a delivery tube notch 510 and can extend within the delivery tube 500 to attach to an inner elongated member 400 at a braid release 400 .
• FIG. 5B depicts a partially implanted braided implant 300 .
• the inner elongated member 400 can be pushed distally, pushing the braided implant 300 out of the delivery tube 500 and microcatheter 600 .
• the implant 300 can invert and begin to form an occlusive sack 308 .
• the inner elongated member 400 can be continued to be pushed distally, pushing more of the braided implant 300 out of the delivery tube 500 .
• the implant 300 can continue to invert and the occlusive sack 308 can expand.
• the inner elongated member 400 can be pushed until the braided implant 300 fully exits the delivery tube.
• the occlusive sack 308 can be fully expanded, and the portion of the braided implant 300 that does not invert to form the occlusive sack 308 can be pushed into the occlusive sack 308 forming an embolic filler braid 310 .
• the embolic filler braid 310 can remain attached to the inner elongated member 400 by a braid release mechanism 404 . While the embolic filler braid 310 is attached to the inner elongated member 400 , the braided implant 300 can be partially or fully retracted by pulling the inner elongated member 400 proximally. Once retracted, the implantation system can be repositioned and the inner elongated member 400 can be pushed distally to re-implant the braided implant 300 .
• the braided implant 300 can be released from the inner elongated member 400 by detaching the braid release mechanism 404 .
• the delivery tube 500 can be pushed distally from the microcatheter 600 , or the microcatheter 600 can be pulled proximally, and the expansion ring 200 can begin to expand from a delivery configuration as shown in FIGS. 5A to 5E to an expanded configuration. As the expansion ring 200 expands, it can begin to disengage the notch 510 in the delivery tube 500 .
• the expansion ring 200 can be made of a memory shape material that has a deformed shape in the delivery configuration that is crimped to fit within the notch 510 in the delivery tube and a predetermined shape that the expansion ring 200 expands to in the expanded or deployed configuration.
• the expansion ring 200 can make contact with bodily fluids, and the temperature of the bodily fluids can cause the expansion ring 200 to expand to the predetermined shape.
• the expansion ring 200 can continue to expand and disengage from the notch 510 in the delivery tube 500 . Once the expansion ring 200 is fully expanded in the deployed configuration, the delivery tube can be extracted.
• FIG. 6 depicts a braided implant in an implanted configuration with an expansion ring in a deployed configuration.
• the delivery tube 500 and microcatheter 600 can be extracted from the patent.
• FIG. 7A depicts a cut-away of an aneurysm 10 with a partially implanted braided implant 300 .
• a delivery catheter 600 can be delivered through a blood vessel 20 to a neck 16 of the aneurysm, and the braided implant 300 can be pushed through the neck 16 into the aneurysm 10 to form an occlusive sack 308 that extends to walls of the aneurysm 10 .
• the partially implanted braided implant 300 can be retracted and repositioned.
• FIG. 7B depicts a cut-away of an aneurysm 10 with a completely implanted braided implant 300 .
• An occlusive sack 308 extends the walls 14 of the aneurysm 10 , and an embolic braid 310 can fill the occlusive sack 308 . Together, the occlusive sack 308 and embolic braid 310 can fill the aneurysm sac 12 .
• the expansion ring 200 can reside near the aneurysm neck 16 and can have extending portions 210 that extend to appose the occlusive sack 308 .
• the expansion ring 200 can have attaching segments 220 that connect the extending portions 210 , and the attaching segments 220 can form a ring or other shape that defines an opening 240 of the expansion ring 200 and occlusive sack 308 .
• FIGS. 8A to 8C depict a braided implant 300 in an implanted configuration and an expansion ring 200 in a deployed configuration.
• the expansion ring 200 can have leaf or petal shaped extending portions 210 connected by attaching segments 220 .
• the expansion ring 200 can have a collapsed configuration as shown in FIG. 2B and expand to a deployed configuration as shown in FIGS. 8A to 8C .
• FIG. 8A depicts a side view of an occlusive sack 308 having an embolic filler braid 310 and the expansion ring 200 .
• FIGS. 8B and 8C illustrate a cross-sectional view of the occlusive sack 308 as indicated in FIG. 8A . Referring to FIG.
• the expansion ring can be constructed with multiple independent sections that are connected together with segment connectors 232 .
• each extending portion 210 can have a connector 232 positioned to connect two halves of each extending portion 210 .
• the occlusive sack 308 can be connected to the expansion ring at the attaching segments 220 , and the extending portions can be free to slide against the occlusive sack 308 as the expansion ring 200 opens to the deployed configuration. As illustrated in FIG.
• the attaching segments 220 can define a first circumference 324 of the occlusive sack 308 near an opening in the occlusive sack 308 , and the extending portions 210 can open the occlusive sack to a larger, second circumference 326 .
• FIGS. 9A and 9B depict a braided implant 300 in an implanted configuration and an expansion ring 300 in a deployed configuration.
• FIG. 9A is a side view
• FIG. 9B is a cross-sectional view as indicated in FIG. 9A .
• the expansion ring 200 can have four segments 230 connected by connectors 232 to form four corners.
• FIGS. 10A and 10B depict an expansion ring 200 in a collapsed configuration.
• the expansion ring 200 can be shaped as shown in FIGS. 10A and 10B in the collapsed configuration and expand to a deployed configuration.
• FIG. 10A depicts the expansion ring 200 within a notch 510 of a delivery tube
• FIG. 10B depicts the expansion ring of FIG. 10A absent the delivery tube.
• the segments 230 can be substantially straight, and bends 234 or connectors (not shown) can join the segments 230 to form a zig zag structure.
• the expansion ring can include attachment tabs 236 for attaching to a braided implant 300 .
• an expansion ring can have any number of segments, bends, and connectors to form a zig-zag shape.
• the zig-zag shape can have a tubular shape, having a substantially uniform circumference along its length.
• the expansion ring can have a tubular shape having a substantially uniform circumference larger than the collapsed circumference or a tapered shape having a first circumference near the occlusive sack opening and a second circumference at a region within an occlusive sack that is larger than the first circumference.
• Expansion rings disclosed herein are preferably formed of a shape memory material such as nickel-titanium alloy, or a shape memory polymer, for example, having a shape memory position in an expanded configuration.
• the expansion rings can be appropriately heat treated so that the expansion ring forms in the desired shape of the expanded shape memory position.
• Each expansion ring can be formed by cutting a tube or a sheet formed of a shape memory material such as nickel-titanium alloy, or shape memory polymer, by a laser
• FIGS. 11 and 12 are flow diagrams outlining example method steps for use of a device or system for treating an aneurysm.
• the method steps can be implemented by any of the example means described herein or by any means that would be known to one of ordinary skill in the art.
• a braided implantation delivery system having a braided implant, a delivery tube, and an expansion component can be provided.
• the braided implant can be attached to the expansion component.
• the expansion component can be engaged with a notch on the delivery tube.
• the braided implant can be implanted into the aneurysm.
• the expansion component can be expanded to disengage the expansion component from the notch.
• the expansion component can be released from the delivery tube, thereby releasing the braided implant from the delivery tube.
• a braided implantation delivery system having a braided implant, a delivery tube, an inner elongated member, and an expansion component can be provided.
• the braided implant can be attached to the expansion component.
• the braided implant can be attached to the inner elongated member.
• the expansion component can engage a notch on the delivery tube.
• the braided implant can be implanted into the aneurysm by pushing the inner elongated member distally, thereby pushing a portion of the braided implant into the aneurysm and forming an occlusive sack within the aneurysm, then detaching the braided implant from the inner elongated member.
• the expansion component can be expanded to disengage the expansion component from the notch.
• the expansion component can release the delivery tube, thereby releasing the braided implant from the delivery tube.
• the expansion component can expand to occlude at least a portion of the neck of the aneurysm and extend the occlusive sack across the neck of the aneurysm.
• the invention contemplates many variations and modifications of a system, device, or method that can be used to treat an aneurysm with a braided implant. Variations can include but are not limited to alternative geometries of elements and components described herein, utilizing any of numerous materials for each component or element (e.g.
• radiopaque materials including radiopaque materials, memory shape metals, etc.
• additional components including components to position the braided implant at a treatment site, extract the braided implant, or eject a portion of the braided implant from the interior of the delivery tube, utilizing additional components to perform functions described herein, or utilizing additional components to perform functions not described herein, for example.

Landscapes

• Health & Medical Sciences (AREA)
• Surgery (AREA)
• Life Sciences & Earth Sciences (AREA)
• Heart & Thoracic Surgery (AREA)
• Molecular Biology (AREA)
• Vascular Medicine (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Reproductive Health (AREA)
• Medical Informatics (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Neurosurgery (AREA)
• Surgical Instruments (AREA)
• Media Introduction/Drainage Providing Device (AREA)
• Prostheses (AREA)

Abstract

Description

Claims (20)

Priority Applications (1)

Applications Claiming Priority (2)

Related Parent Applications (1)

Publications (1)

Family

ID=68066610

Family Applications (2)

Family Applications Before (1)

Country Status (12)

Cited By (4)

Families Citing this family (6)

Citations (4)

Family Cites Families (394)

• 2018
  • 2018-09-25 US US16/140,836 patent/US11123077B2/en active Active
• 2019
  • 2019-08-20 IL IL26880319A patent/IL268803A/en unknown
  • 2019-08-23 AU AU2019219845A patent/AU2019219845A1/en not_active Abandoned
  • 2019-09-04 CA CA3053917A patent/CA3053917A1/en not_active Abandoned
  • 2019-09-18 RU RU2019129351A patent/RU2019129351A/en unknown
  • 2019-09-23 TW TW108134158A patent/TW202023483A/en unknown
  • 2019-09-23 BR BR102019019849A patent/BR102019019849A2/en not_active IP Right Cessation
  • 2019-09-23 KR KR1020190116630A patent/KR20200035222A/en unknown
  • 2019-09-24 EP EP19199204.9A patent/EP3628242A1/en not_active Withdrawn
  • 2019-09-24 JP JP2019172576A patent/JP7467055B2/en active Active
  • 2019-09-25 CN CN201910909903.4A patent/CN110934620A/en not_active Withdrawn
  • 2019-09-25 CO CONC2019/0010337A patent/CO2019010337A1/en unknown
• 2021
  • 2021-09-09 US US17/470,049 patent/US20210401439A1/en not_active Abandoned

Patent Citations (4)

Also Published As

Similar Documents

Legal Events